Literature DB >> 21633533

Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats.

Tomohiro Kudo1, Shinichi Okamura, Yajing Zhang, Takashige Masuo, Masatomo Mori.   

Abstract

AIM: To examine the efficacy of glycyrrhizin preparation (GL-p) in the treatment of a rat model of ulcerative colitis (UC).
METHODS: Experimental colitis was induced by oral administration of dextran sodium sulfate. Rats with colitis were intrarectally administered GL-p or saline. The extent of colitis was evaluated based on body weight gain, colon wet weight, and macroscopic damage score. The expression levels of pro-inflammatory cytokines and chemokines in the inflamed mucosa were measured by cytokine antibody array analysis. The effect of GL-p on myeloperoxidase (MPO) activity in the inflamed mucosa and purified enzyme was assayed.
RESULTS: GL-p treatment significantly ameliorated the extent of colitis compared to sham treatment with saline. Cytokine antibody array analysis showed that GL-p treatment significantly decreased the expression levels of pro-inflammatory cytokines and chemokines, including interleukin (IL)-1β, IL-6, tumor necrosis factor-α, cytokine-induced neutrophil chemoattractant-2, and monocyte chemoattractant protein-1 in the inflamed mucosa. Furthermore, GL-p inhibited the oxidative activity of mucosal and purified MPO.
CONCLUSION: GL-p enema has a therapeutic effect on experimental colitis in rats and may be useful in the treatment of UC.

Entities:  

Keywords:  Carboxymethylcellulose; Chemokine; Colitis; Cytokine; Dextran sodium sulfate; Enema; Glycyrrhizin; Myeloperoxidase; Protein array; Ulcerative colitis

Mesh:

Substances:

Year:  2011        PMID: 21633533      PMCID: PMC3092875          DOI: 10.3748/wjg.v17.i17.2223

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

2.  Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis.

Authors:  Hao Yuan; Wan-Sheng Ji; Ke-Xiang Wu; Jian-Xin Jiao; Liang-Hua Sun; Yong-Tang Feng
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

Authors:  Y Arase; K Ikeda; N Murashima; K Chayama; A Tsubota; I Koida; Y Suzuki; S Saitoh; M Kobayashi; H Kumada
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

Review 4.  Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.

Authors:  T G van Rossum; A G Vulto; R A de Man; J T Brouwer; S W Schalm
Journal:  Aliment Pharmacol Ther       Date:  1998-03       Impact factor: 8.171

5.  Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis.

Authors:  S A Radema; S J van Deventer; A Cerami
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

6.  Antibody array analysis of peripheral and blood cytokine levels in rats after masseter inflammation.

Authors:  Mineo Watanabe; Wei Guo; Shiping Zou; Shinichi Sugiyo; Ronald Dubner; Ke Ren
Journal:  Neurosci Lett       Date:  2005-03-16       Impact factor: 3.046

7.  A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients.

Authors:  Kenji Ikeda; Yasuji Arase; Masahiro Kobayashi; Satoshi Saitoh; Takashi Someya; Tetsuya Hosaka; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Fumitaka Suzuki; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

8.  Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema.

Authors:  M Campieri; P Paoluzi; G D'Albasio; G Brunetti; A Pera; L Barbara
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

9.  Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice.

Authors:  Y Arai; H Takanashi; H Kitagawa; I Okayasu
Journal:  Cytokine       Date:  1998-11       Impact factor: 3.861

Review 10.  Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds.

Authors:  Marjan Nassiri Asl; Hossein Hosseinzadeh
Journal:  Phytother Res       Date:  2008-06       Impact factor: 5.878

View more
  12 in total

1.  Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells.

Authors:  Xiangyu Chen; Dai Fang; Lingyun Li; Liyong Chen; Qirui Li; Feili Gong; Min Fang
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

2.  Animal Models and Pathogenesis of Ulcerative Colitis.

Authors:  Xin Gao; Jia Li; Xueping Pang; Kaiyuan Cong; Chunlei Jiang; Bingxuan Han; Jiawei Gao; Zhihao Wang; Jiangshan Hu; Kaijun Wen; Xinfa Ye; Liwen Dou
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

Review 3.  Herbal medicine in the treatment of ulcerative colitis.

Authors:  Fei Ke; Praveen Kumar Yadav; Liu Zhan Ju
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

Review 4.  The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders.

Authors:  Camila Dos Santos Leite; Gabriel Alves Bonafé; Juliana Carvalho Santos; Carlos Augusto Real Martinez; Manoela Marques Ortega; Marcelo Lima Ribeiro
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

Review 5.  Natural product-derived drugs for the treatment of inflammatory bowel diseases.

Authors:  Young-Eun Joo
Journal:  Intest Res       Date:  2014-04-29

Review 6.  Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative Colitis.

Authors:  Chunyan Wang; Xudong Tang; Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-12       Impact factor: 2.629

7.  Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice.

Authors:  Jeong-Ho Song; Ju-Won Lee; Beomsoo Shim; Chang-Yeol Lee; Sooyong Choi; Chulhun Kang; Nak-Won Sohn; Jung-Won Shin
Journal:  Molecules       Date:  2013-12-17       Impact factor: 4.411

8.  Korean Traditional Medicine (Jakyakgamcho-tang) Ameliorates Colitis by Regulating Gut Microbiota.

Authors:  Seung-Ho Seo; Tatsuya Unno; Seong-Eun Park; Eun-Ju Kim; Yu-Mi Lee; Chang-Su Na; Hong-Seok Son
Journal:  Metabolites       Date:  2019-10-14

9.  Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice.

Authors:  Roberta Vitali; Francesca Palone; Salvatore Cucchiara; Anna Negroni; Leonardo Cavone; Manuela Costanzo; Marina Aloi; Anna Dilillo; Laura Stronati
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Protective effect of the methanolic extract of malva parviflora l. leaves on acetic acid-induced ulcerative colitis in rats.

Authors:  Aisha Dugani; Bushra Dakhil; Soad Treesh
Journal:  Saudi J Gastroenterol       Date:  2016 May-Jun       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.